EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF study

Claire Edmondson iD, Nicole Westrupp, Christopher Short, Paul Seddon, Catherine Olden, Colin Wallis, Malcolm Brodlie, Francis Baxter, Jonathan McCormick, Susan MacFarlane, Richard Brooker, Margaret Connon und 14 weitere

Pediatric Pulmonology · 2023-10 · 58 (10) · 2871-2880

DOI: 10.1002/ppul.26602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 28.07.2023. Verfasst von Claire Edmondson und 25 weiteren Autor:innen. Beteiligte Einrichtung: NHLI, Imperial College, London, UK. Hauptthemen laut MEDLINE: Cystic Fibrosis, COVID-19. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cystic Fibrosis Trust, Cystic Fibrosis Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Handheld spirometry allows monitoring of lung function at home, of particular importance during the COVID‐19 pandemic. Pediatric studies are unclear on whether values are interchangeable with traditional, clinic‐based spirometry. We aimed to assess differences between contemporaneous, home (unsupervised) and clinic (supervised) spirometry and the variability of the former. The accuracy of the commercially available spirometer used in the study was also tested.

Methods

Data from participants in the Clinical Monitoring and Biomarkers to stratify severity and predict outcomes in children with cystic fibrosisc (CLIMB‐CF) Study aged ≥ 6 years who had paired (±1 day) clinic and home forced expiratory volume in 1 s (FEV 1 ) readings were analyzed. Variability during clinical stability over 6‐months was assessed. Four devices from Vitalograph were tested using 1 and 3 L calibration syringes.

Results

Sixty‐seven participants (median [interquartile range] age 10.7 [7.6−13.9] years) provided home and clinic FEV 1 data pairs. The mean (SD) FEV 1 % bias was 6.5% [±8.2%]) with wide limits of agreement (−9.6% to +22.7%); 76.2% of participants recorded lower results at home. Coefficient of variation of home FEV 1 % during stable periods was 9.9%. Data from the testing of the handheld device used in CLIMB‐CF showed a potential underread.

Conclusion

In children and adolescents, home spirometry using hand‐held equipment cannot be used interchangeably with clinic spirometry. Home spirometry is moderately variable during clinical stability. New handheld devices underread, particularly at lower volumes of potential clinical significance for smaller patients; this suggests that supervision does not account fully for the discrepancy. Opportunities should be taken to obtain dual device measurements in clinic, so that trend data from home can be utilized more accurately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCOVID-19AdolescentHumansChildPandemicsSpirometryForced Expiratory Volume

Stichwörter der Autor:innen

cystic fibrosisremote monitoringremote spirometryunsupervised spirometry

Autor:innen und Institutionen

  • NHLI, Imperial College, London, UK.
  • Royal Brompton Hospital, Part of Guy's & St Thomas' NHS Trust, London, UK.
  • Royal Alexandra Children's Hospital, Brighton, UK.
  • Great Ormond Street Hospital CF Unit, London, UK.
  • Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

ORCID-Profile: Claire Edmondson, Rebecca Thursfield, John Wallenburg, Jane C Davies

Förderung

  • Cystic Fibrosis Trust
  • Cystic Fibrosis Canada

Zitieren

APA

Edmondson, C., Westrupp, N., Short, C., Seddon, P., Olden, C., Wallis, C., Brodlie, M., Baxter, F., McCormick, J., MacFarlane, S., Brooker, R., Connon, M., Ghayyda, S., Blaikie, L., Thursfield, R., Brown, L., Price, A., Fleischer, E., Hughes, D., …, & Davies, J. C. (2023). Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF study. Pediatric Pulmonology, 58(10), 2871-2880. https://doi.org/10.1002/ppul.26602

Vancouver

Edmondson C, Westrupp N, Short C, Seddon P, Olden C, Wallis C, et al. Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF study. Pediatric Pulmonology. 2023;58(10):2871-2880. doi:10.1002/ppul.26602

BibTeX
@article{Edmondson2023,
  author = {Edmondson, Claire and Westrupp, Nicole and Short, Christopher and Seddon, Paul and Olden, Catherine and Wallis, Colin and Brodlie, Malcolm and Baxter, Francis and McCormick, Jonathan and MacFarlane, Susan and Brooker, Richard and Connon, Margaret and Ghayyda, Salim and Blaikie, Lesley and Thursfield, Rebecca and Brown, Lynsey and Price, April and Fleischer, Erin and Hughes, Daniel and Donnelly, Christine and Rosenthal, Mark and Wallenburg, John and Brownlee, Keith and Alton, Eric W F W and Bush, Andrew and Davies, Jane C},
  title = {Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF study},
  journal = {Pediatric Pulmonology},
  year = {2023},
  volume = {58},
  number = {10},
  pages = {2871--2880},
  doi = {10.1002/ppul.26602}
}
Kostenlos starten →